MENLO THERAPEUTICS INC - COM (MNLO)

CUSIP: 586858102

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
83,515,779
Share change
+48,931,400
Total reported value
$144,532,313
Price per share
$1.73
Number of holders
100
Value change
+$78,079,397
Number of buys
86
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 586858102?
CUSIP 586858102 identifies MNLO - MENLO THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MENLO THERAPEUTICS INC - COM (MNLO) as of Q2 2020

As of 30 Jun 2020, MENLO THERAPEUTICS INC - COM (MNLO) was held by 100 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 83,515,779 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, 683 Capital Management, LLC, DSC Advisors, L.P., AXA, Vivo Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Healthcare Value Capital, LLC. This page lists 100 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.